Haemonetics | HAE - Operating Expenses


Haemonetics reported $134.99M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Avanos Medical USD 782.1M 625.97M Mar/2026
Baxter International USD 6.04B 2.85B Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Boston Scientific USD 4.15B 107M Mar/2026
Cerus USD 34.78M 2.98M Dec/2024
Cooper Companies USD 1.11B 301.2M Mar/2026
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.34B 63M Mar/2026
Globus Medical USD 595.85M 49.26M Mar/2026
Haemonetics USD 134.99M 1.26M Dec/2025
ICU Medical USD 514.62M 4.48M Dec/2025
Intuitive Surgical USD 1.91B 89.8M Mar/2026
Masimo USD 326.2M 2.4M Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Merit Medical Systems USD 337.72M 2.02M Mar/2026
Neogen USD 214.5M 15.57M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Quidel USD 1.85B 1.09B Mar/2026
ResMed USD 925.74M 525K Mar/2026
STAAR Surgical USD 76.12M 7.38M Mar/2026
Steris USD 1.27B 51.5M Mar/2026
Stryker USD 4.92B 284M Mar/2026
Surmodics USD 29.51M 274.86M Jun/2025
Teleflex USD 3.08B 2.55B Mar/2026
Terumo JPY 268.87B 16.12B Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
US Physical Therapy USD 185.87M 86K Mar/2026
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026